once monthly glp 1 Medicare begins covering GLP-1 drugs for weight loss Glucagon-like peptide-1 receptor: mechanisms and

Access to GLP-1s is only available to people with a BMI of 30 or higher, or 27 and higher with a weight-related health condition like high blood pressure, high cholesterol, or type 2 diabetes

This precision medicine approach transforms GLP-1 therapy from a standard treatment into a truly personalized intervention

N Engl J Med 2021

Elevated potassium levels, known as hyperkalemia, must be monitored carefully because, if left unchecked, they can lead to serious complications, including abnormal heart rhythms and, in severe cases, death. Accordingly, it is generally not prescribed to people with certain underlying health conditions, including kidney disease, where the risk of elevated potassium levels is higher, or those with very low blood pressure

doi: 10.1053/j.gastro.2015.04.014 quiz e15-6